Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.8300
-0.0035 (-0.42%)
At close: Aug 13, 2025, 4:00 PM
0.8111
-0.0189 (-2.28%)
Pre-market: Aug 14, 2025, 9:03 AM EDT
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $16.23 million as of August 14, 2025. Its market cap has decreased by -71.01% in one year.
Market Cap
16.23M
Enterprise Value
11.73M
1-Year Change
-71.01%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since February 12, 2007, Lexaria Bioscience's market cap has decreased from $19.40M to $16.23M, a decrease of -16.32%. That is a compound annual growth rate of -0.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 16.20M | -55.86% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 2.67% |
| Dec 31, 2020 | 22.50M | -24.75% |
| Dec 31, 2019 | 29.90M | -58.30% |
| Dec 31, 2018 | 71.70M | -38.87% |
| Dec 29, 2017 | 117.30M | 624.07% |
| Dec 30, 2016 | 16.20M | 131.43% |
| Dec 31, 2015 | 7.00M | 125.81% |
| Dec 31, 2014 | 3.10M | 342.86% |
| Dec 31, 2013 | 700.00K | -12.50% |
| Dec 31, 2012 | 800.00K | -77.78% |
| Dec 30, 2011 | 3.60M | -7.69% |
| Dec 31, 2010 | 3.90M | 69.57% |
| Dec 31, 2009 | 2.30M | 130.00% |
| Dec 31, 2008 | 1.00M | -94.71% |
| Dec 31, 2007 | 18.90M | -2.58% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 591.97B |
| Johnson & Johnson | 419.12B |
| AbbVie | 354.08B |
| UnitedHealth Group | 245.67B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.69B |
| Novo Nordisk | 223.00B |